Stay updated on bb21217 Efficacy in Myeloma Clinical Trial
Sign up to get notified when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.

Latest updates to the bb21217 Efficacy in Myeloma Clinical Trial page
- Check3 days agoChange DetectedAdded related topics such as Multiple myeloma and MedlinePlus Genetics, and updated the revision from v3.3.3 to v3.3.4.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRemoved the condition 'Multiple myeloma' and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.2%

- Check24 days agoChange DetectedLocations section updated to list participating sites by state (California, Florida, Georgia, Illinois, Massachusetts, Minnesota, New Jersey, New York, Tennessee). Revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check46 days agoChange DetectedAdded related topics links for Multiple myeloma and MedlinePlus Genetics under Related Topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedThe PubMed publications note now states that publications are automatically filled from PubMed and may not be about the study, and the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page no longer displays a government funding notice and removes the 'Multiple myeloma' entry and the related topic 'MedlinePlus Genetics'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to bb21217 Efficacy in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.